Emphasis
The emphasis is on: simulation and development of new detector materials and methods of detection for nuclear imaging; collimators and other selective signal modulators, and readout methods that enhance the signal quality of detecting isotope emissions; designs of novel camera geometries for dedicated, general or multi-purpose imaging; and correction methods that compensate for the radiation physics properties to improve the clinical reliability of the image (reconstructions algorithms). Of interest are improvements in collimation and camera designs for SPECT, improvements and corrections for interaction events in PET detectors, enhancement to time of flight (TOF) PET image generation methods, reproducible and standardized quantification as well as new detector materials.
Relevance
The emphasized topics are meant to lead toward: improved clinical SPECT and PET cameras or next-generation camera systems; novel simulations, reconstruction algorithms, or artifact corrections for enhancing diagnostic images; and multi-modal camera designs. Investigating the associated dosimetry estimations leads to decreased risk in diagnostic imaging studies in patients.
Examples of emphasis
- evaluation of new semiconductor, scintillation and other novel radiation detectors
- replacing photomultiplier tubes with novel photoconversion techniques
- readout electronics for measuring radiation interactions
- techniques for improved camera spatial resolution and sensitivity
- new approaches for improving coincidence measurements for TOF-PET
- application of secondary emissions (e.g. bremsstrahlung, Cherenkov) for imaging
- novel camera designs applicable to dedicated imaging of specific organs
- combining modalities for clinically relevant hybrid systems (e.g. coupling SPECT and PET to x-ray/ultrasound CT and/or to MRI or other modalities)
- software algorithms and imaging protocols to estimate patient dosimetry
- design of improved spatial and temporal resolution SPECT systems
- methods of measuring and correcting for patient motion
- new diagnostics applied to image-guided therapy and theranostics
Notes
- clinical application of image-guided therapy and theranostics is supported by the Image-Guided Interventions program
- development of novel imaging molecular agents is supported by the Molecular Imaging program
- novel evaluation of images
Notice of Special Interest in Radiation Monitoring for Trauma Care
Related News
Positron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative advance from scientists at St. Jude Children’s Research Hospital is enhancing the technique’s ability to check for signs of neurological disease. The researchers repurposed the drug edaravone, an antioxidant used to treat amyotrophic lateral sclerosis (ALS), as a probe to be used with central nervous system PET imaging. With this technique, the researchers can detect oxidative stress, which leads to brain damage, offering a clear path to detecting neurological conditions. Source: St. Jude Children's Research Hospital
Rice University bioengineers have created a groundbreaking construction kit for designing custom sense-and-respond circuits in human cells. Published in Science, this research marks a significant advancement in synthetic biology, with the potential to transform treatments for complex diseases such as cancer and autoimmune disorders. Source: SciTech Daily
In an effort to greatly expand accessibility, this compact fluorescence-guided surgery system, evaluated in mice, is crafted from cost-effective and off-the-shelf components.
Rice University bioengineers have developed a new construction kit for building custom sense-and-respond circuits in human cells. The research, published in the journal Science, represents a major breakthrough in the field of synthetic biology that could revolutionize therapies for complex conditions like autoimmune disease and cancer. Source: Rice University News & Media Relations
Releasing a drug selectively in specific locations in the body, including the brain, has been challenging. Researchers at the University of Utah have tackled the problem by designing ultrasound-sensitive nanoparticles that release a drug at the targeted site when activated by focused ultrasound.